Roivant Sciences Ltd.
Financial ratios & Valuation

Forward Multiples (2026 – 2029)

2026202720282029
Price/Earnings ratio
-10.01-22.55102.5812.04
Price/Sales ratio
31.5112.605.403.22
Earnings per Share (EPS)
$-1.18$-0.52$0.11$0.98

Historical Multiples (2020 – 2022)

2020 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
1.86-3.91-5.07-3.91
Price/Sales ratio
33.0859.84117.4833.08
Price/Book Value ratio
1.101.995.541.10
Price/Cash Flow ratio
-2.93-4.88-4.61-4.61
Price/Free Cash Flow ratio
-2.92-4.75-4.48-4.48
Price/Earnings Growth ratio
N/A-0.570.600.60
Dividend Yield
N/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
98.32%83.78%79.00%83.78%
Operating Profit Margin
-786.57%-2444.81%-2445.62%-2444.81%
Pretax Profit Margin
-828.76%-1670.85%-2576.38%-1670.85%
Net Profit Margin
1773.56%-1528.88%-2316.63%-1528.88%
Effective Tax Rate
-1.26%-0.03%-0.78%-1.26%
Return on Assets
48.46%-32.69%-47.43%-32.69%
Return On Equity
59.07%-51.01%-81.05%-51.01%
Return on Capital Employed
-22.32%-56.30%-56.32%-56.30%
Liquidity Ratios
Current Ratio
N/AN/A6.73N/A
Quick Ratio
24.0911.646.2511.64
Cash ratio
23.7211.176.2511.17
Days of Sales Outstanding
82.3844.44N/A44.44
Days of Inventory outstanding
0.00N/AN/AN/A
Operating Cycle
82.3844.44N/A44.44
Days of Payables Outstanding
3.32K1.40K1.85K1.85K
Cash Conversion Cycle
-3.24K-1.36K-1.85K-3.24K
Debt Ratios
Debt Ratio
0.040.080.350.04
Debt Equity Ratio
0.050.120.810.05
Long-term Debt to Capitalization
0.050.110.310.05
Total Debt to Capitalization
0.050.110.330.05
Interest Coverage Ratio
N/AN/AN/AN/A
Cash Flow to Debt Ratio
-6.54-3.22-2.39-6.54
Company Equity Multiplier
1.211.562.301.21
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-11.25-12.25-25.45-12.25
Free Cash Flow / Operating Cash Flow Ratio
1.001.021.021.00
Cash Flow Coverage Ratio
-6.54-3.22-2.39-6.54
Short Term Coverage Ratio
-97.18N/A-23.15-97.18
Dividend Payout Ratio
N/AN/AN/AN/A